by Joris | Jan 28, 2026 | Blog, News, Person, SURE Technology
JURA Bio and Annogen Announce Research Collaboration to Advance Precision Gene Expression Engineering Through AI-Driven Design and Functional Genomics Partnership brings together JURA’s variational synthesis platform and Annogen’s SuRE™ technology to...
by Joris | Jan 26, 2026 | Application notes, Blog, News, Person, SURE Technology
Twist Webinar: Bespoke Functional Genomics for AI Presented by Dr. Joris van Arensbergen Founder & CEO, Annogen Covered in this Webinar How Annogen generates SuRE™ datasets that support the design of DNA regulatory element How combined with Twist Bioscience’s...
by Joris | May 12, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 12, 2025 Orchard Therapeutics, a Kyowa Kirin company focused on innovative gene therapies, and Annogen B.V., experts in bespoke promoter design and gene expression engineering, today announced the successful identification of...
by Joris | May 7, 2025 | News, SURE Technology
Amsterdam, The Netherlands – May 7, 2025 Ascend Advanced Therapies and Annogen will combine their expertise in AAV biology, vector manufacturing and genetic engineering to improve the quality of recombinant AAV particles used in gene therapy applications. While AAV...
by Martijn Kelder | Feb 25, 2025 | Blog, SURE Technology
What makes Annogen’s promoter design stand-out from other providers? A valid question. Let’s put this in historical context. Gene promoter design is nothing new: as early as the 1980’s, researchers began to understand different components within promoters, e.g. TATA...
